COST-EFFECTIVENESS OF VARIOUS COMBINATIONS OF HUMAN PAPILLOMAVIRUS (HPV)-BASED TESTING, INCLUDING GENOTYPING FOR HPV 16/18, FOR CERVICAL CANCER SCREENING

被引：2
|
作者：
Huh, W. [1 ]
Williams, E. [2 ]
Bramley, T. [2 ]
Huang, J. [3 ]
Poulios, N. [3 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Xcenda, Palm Harbor, FL USA
[3] Roche Mol Diagnost, Pleasanton, CA USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.699
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A142 / A143
页数：2
相关论文
共 50 条
  • [21] Role of human papillomavirus (HPV) testing in primary cervical cancer screening
    Ratnam, S
    Franco, E
    Ferenczy, A
    EUROGIN 2000: 4TH INTERNATIONAL MULTIDISCIPLINARY CONGRESS, 2000, : 27 - 28
  • [22] Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
    Bian, Mei-Lu
    Cheng, Jiao-Ying
    Ma, Li
    Cong, Xiao
    Liu, Jun
    Chen, Ying
    Chen, Xi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (05) : 1332 - 1336
  • [23] HPV16/18 vaccination to prevent cervical cancer in The Netherlands: Model-based cost-effectiveness
    Coupe, Veerle M. H.
    van Ginkel, Joost
    de Melker, Hester E.
    Snijders, Peter J. F.
    Meijer, Chris J. L. M.
    Berkhof, Johannes
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (04) : 970 - 978
  • [24] Cost-effectiveness of HPV 16, 18 vaccination in Brazil
    Goldie, Sue J.
    Kim, Jane J.
    Kobus, Katie
    Goldhaber-Fiebert, Jeremy D.
    Salomon, Joshua
    O'Shea, Meredith K. H.
    Xavier Bosch, F.
    de Sanjose, Silvia
    Franco, Eduardo L.
    VACCINE, 2007, 25 (33) : 6257 - 6270
  • [25] HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile
    Lagos, Marcela
    Van De Wyngard, Vanessa
    Poggi, Helena
    Cook, Paz
    Viviani, Paola
    Barriga, Maria Isabel
    Pruyas, Martha
    Ferreccio, Catterina
    INFECTIOUS AGENTS AND CANCER, 2015, 10
  • [26] HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile
    Marcela Lagos
    Vanessa Van De Wyngard
    Helena Poggi
    Paz Cook
    Paola Viviani
    María Isabel Barriga
    Martha Pruyas
    Catterina Ferreccio
    Infectious Agents and Cancer, 10
  • [27] CLINICAL-ECONOMIC MODELING ANALYSIS OF HUMAN PAPILLOMAVIRUS (HPV) CO-TESTING WITH GENOTYPING VERSUS PRIMARY HPV TESTING FOR CERVICAL CANCER SCREENING
    Felix, J. C.
    Lacey, M. J.
    Miller, J. D.
    Lenhart, G. M.
    Kulkarni, R.
    VALUE IN HEALTH, 2015, 18 (07) : A353 - A353
  • [28] Human papillomavirus (HPV) genotyping by HPV DNA chip in cervical cancer and precancerous lesions
    Lee, G. -Y
    Kim, S. -M.
    Rim, S. -Y
    Choi, H. -S.
    Park, C. -S.
    Nam, J. -H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (01) : 81 - 87
  • [29] Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model
    Usher, Cara
    Tilson, Lesley
    Olsen, Jens
    Jepsen, Martin
    Walsh, Cathal
    Barry, Michael
    VACCINE, 2008, 26 (44) : 5654 - 5661
  • [30] HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
    Kares, Saara
    Veijalainen, Olga
    Kholova, Ivana
    Tirkkonen, Mika
    Vuento, Risto
    Huhtala, Heini
    Tuimala, Veronica
    Maenpaa, Johanna
    Kujala, Paula
    APMIS, 2019, 127 (11) : 710 - 716
12345